1 recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
Follow Pcv: new trials by email Literature Review of Pcv trials Research Report on Pcv
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease Synthetic long peptide personalized cancer vaccine, Poly ICLC, Signatera or Altera testing - Muscle-Invasive Bladder Carcinoma, Gastroesophageal Adenocarcinoma | Phase 1 | Recruiting | Washington University School of Medicine | 64 | 2025-03-20 | 2026-09-21 |
Carcinoma, Non-Small-Cell Lung (1) · Melanoma (1) · Urinary Bladder Neoplasms (1)
Washington University School of Medicine (1)
United States (1)